OBWG
VRTX icon

Onyx Bridge Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Onyx Bridge Wealth Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Sell
431
-63
-13% -$27.9K 0.02% 356
2026
Q1 		$221K Buy
494
+3
+0.6% +$1.4K 0.02% 331
2025
Q4 		$223K Buy
+491
New +$212K 0.02% 323
2024
Q4 		– Sell
-724
Closed -$337K – 302
2024
Q3 		$337K Buy
+724
New +$348K 0.05% 203

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Onyx Bridge Wealth Group's VRTX Position: Q2 2026 in Review

Onyx Bridge Wealth Group reduced its Vertex Pharmaceuticals (VRTX) stake by 13% in Q2 2026, selling an estimated $27.9K and leaving 431 shares worth $214K. The position accounts for 0.02% of the portfolio, ranked #356.

Onyx Bridge Wealth Group first reported a position in VRTX in Q3 2024 and has held it in 4 quarters since. The position peaked at $337K in Q3 2024. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Onyx Bridge Wealth Group held 431 shares of Vertex Pharmaceuticals worth $214K as of Q2 2026.
  • Onyx Bridge Wealth Group sold 63 Vertex Pharmaceuticals shares in Q2 2026, an estimated $27.9K.
  • Vertex Pharmaceuticals made up 0.02% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #356 holding.
  • Onyx Bridge Wealth Group first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • Onyx Bridge Wealth Group's Vertex Pharmaceuticals position peaked at $337K in Q3 2024.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.